Know Cancer

or
forgot password

Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome


N/A
18 Years
N/A
Open (Enrolling)
Both
Gastrinoma, Zollinger Ellison Syndrome

Thank you

Trial Information

Evaluation of the Gastrinoma in Patients With Zollinger-Ellison Syndrome


This protocol concerns the approach to the localization and management of the tumor in
patients with Zollinger-Ellison syndrome. It details the diagnostic imaging tests to be used
to localize the tumor and the subsequent management of the tumor.

Inclusion Criteria


- INCLUSION CRITERIA:

New patients will be evaluated initially as described in the protocol entitled,
"Diagnostic evaluation of patients with suspected abnormalities of gastric secretion"
(89-DK-0005).

Only those patients that are being treated under the protocol entitled, "Medical Therapy
of Zollinger-Ellison Syndrome" (protocol # 89-DK-0015) will be entered into this tumor
localization and management protocol.

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Stephen A Wank, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Authority:

United States: Federal Government

Study ID:

900137

NCT ID:

NCT00001254

Start Date:

May 1990

Completion Date:

Related Keywords:

  • Gastrinoma
  • Zollinger Ellison Syndrome
  • Islet Cell Tumors
  • Gastrinoma
  • Zollinger-Ellison Syndrome

Name

Location
National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland  20892